We are live on ! Find out more
TBIO

Telesis Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 27th of September, 2024.

Back to rankings

47 hedge funds and large institutions have $92.9M invested in Telesis Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

23% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 13

9% more funds holding

Funds holding: 43 → 47 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

50% less capital invested

Capital invested by funds: $187M → $92.9M (-$93.9M)

Holders
47
Holders Change
+4
Holders Change %
+9.3%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
16
Reduced
13
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$15.5M
2
OAM
Ophir Asset Management
Australia
+$3.35M
3
PM
Penbrook Management
New York
+$1.21M
4
Goldman Sachs
Goldman Sachs
New York
+$1.11M
5
State of Tennessee, Department of Treasury
State of Tennessee, Department of Treasury
Tennessee
+$433K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$8.54M
2
PVI
Pura Vida Investments
New York
-$6.18M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$6.08M
4
PA
Perceptive Advisors
New York
-$4.59M
5
WP
Woodline Partners
California
-$1.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
NV
1
Northpond Ventures
Maryland
$52.9M – – –
Franklin Resources
2
Franklin Resources
California
$14.9M +$15.5M +102,493 +200%
OAM
3
Ophir Asset Management
Australia
$7.06M +$3.35M +22,081 +43%
TCM
4
TimesSquare Capital Management
New York
$3.13M -$189K -1,244 -4%
BlackRock
5
BlackRock
New York
$2.53M -$114K -755 -3%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.94M +$396K +2,610 +15%
WP
7
Woodline Partners
California
$1.61M -$1.21M -7,991 -32%
Millennium Management
8
Millennium Management
New York
$1.34M -$8.54M -56,325 -80%
RI
9
RTW Investments
New York
$1.07M – – –
State Street
10
State Street
Massachusetts
$1.05M +$412K +2,715 +33%
FAM
11
Fred Alger Management
New York
$839K -$7.13K -47 -0.5%
Goldman Sachs
12
Goldman Sachs
New York
$830K +$1.11M +7,292 +564%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$801K +$228K +1,503 +22%
PM
14
Penbrook Management
New York
$774K +$1.21M +8,009 New
Northern Trust
15
Northern Trust
Illinois
$383K +$37K +244 +7%
State of Tennessee, Department of Treasury
16
State of Tennessee, Department of Treasury
Tennessee
$276K +$433K +2,857 New
Bank of America
17
Bank of America
North Carolina
$233K +$320K +2,111 +697%
KJHP
18
K.J. Harrison & Partners
Ontario, Canada
$215K +$337K +2,222 New
Charles Schwab
19
Charles Schwab
California
$140K +$87K +574 +66%
Rafferty Asset Management
20
Rafferty Asset Management
New York
$121K +$190K +1,253 New
SO
21
STRS Ohio
Ohio
$120K – – –
DDC
22
DF Dent & Co
Maryland
$107K +$168K +1,111 New
Barclays
23
Barclays
United Kingdom
$105K +$165K +1,085 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$93K +$5.61K +37 +4%
Morgan Stanley
25
Morgan Stanley
New York
$68K -$6.22K -41 -5%
1
2 3

TBIO Hedge Fund Activity: Q1 2022 in Review

47 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Telesis Bio, Inc. Common Stock (TBIO) for Q1 2022, worth a combined $92.9M — down 50% from $187M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TBIO positions and 9 closed out — a net gain of 4 holders — while 16 added to existing stakes and 13 trimmed.

The largest buyer was Franklin Resources, adding an estimated $15.5M. The largest seller was Millennium Management, cutting an estimated $8.54M.

  • 47 institutional investors held Telesis Bio, Inc. Common Stock (TBIO) as of Q1 2022, up from 43 in Q4 2021.
  • Funds reported $92.9M of Telesis Bio, Inc. Common Stock stock for Q1 2022, down 50% quarter-over-quarter.
  • 13 funds opened new Telesis Bio, Inc. Common Stock positions in Q1 2022 and 9 closed out, a net change of +4 holders.
  • The largest Telesis Bio, Inc. Common Stock buyer in Q1 2022 was Franklin Resources, an estimated $15.5M added.
  • The largest Telesis Bio, Inc. Common Stock seller in Q1 2022 was Millennium Management, an estimated $8.54M sold.

Based on aggregated 13F filings for Q1 2022.